What is the extent of use of montelukast in allergic rhinitis?

Montelukast is a leukotriene receptor antagonist that plays a versatile role in managing allergic rhinitis and asthma. Its use is established in both regular treatment and as an adjunctive therapy for asthma.

In the context of allergic rhinitis, montelukast acts by blocking leukotriene receptors, which are involved in the inflammatory response associated with allergic reactions. This mechanism helps alleviate symptoms such as nasal congestion, rhinorrhea, itching, and sneezing. While many treatment options for allergic rhinitis, such as intranasal corticosteroids and antihistamines, are used primarily for symptom relief, montelukast can be beneficial for individuals who also have asthma, making it effective for those patients experiencing both conditions.

Using montelukast as part of a comprehensive management plan allows for a reduction in the overall symptom burden. It is particularly helpful for individuals who have persistent allergic rhinitis and asthma, as montelukast addresses both conditions. This dual efficacy underscores its role in regular treatment regimens rather than limiting its use to situations such as acute attacks or only secondary treatment.

Thus, its versatility in managing both allergic rhinitis and complementing asthma therapy confirms its classification as beneficial for regular treatment in these cases.